Latest / Pharmacy Podcast Network / inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part Five
Transcript
- 0:00Speaker 1: A special thank you to our sponsors for this year's
- 0:02Speaker 1: coverage of Inspire 2026. Your support makes our coverage possible.
- 0:08Speaker 1: And now, a quick message before this episode begins.
- 0:14Speaker 2: Clearway Health is transforming specialty pharmacy for hospitals, health systems,
- 0:19Speaker 2: and the patients they serve. More than a specialty pharmacy partner,
- 0:23Speaker 2: Clearway Health is an extension of the care team. Working
- 0:26Speaker 2: directly with hospitals and health systems across the country, Clearway
- 0:29Speaker 2: Health helps plan, design, build, and optimize specialty pharmacy programs
- 0:34Speaker 2: that improve access, reduce barriers, and deliver better outcomes for
- 0:38Speaker 2: patients with complex medical conditions. Through their embedded care model,
- 0:42Speaker 2: Clearway Health places pharmacists and patient liaisons directly into clinical workflows,
- 0:48Speaker 2: supporting providers with prior authorizations, financial assistance coordination, and patient education,
- 0:53Speaker 2: freeing up care teams to focus on what matters most,
- 0:56Speaker 2: the patient. Powered by advanced technology and real-time data insights,
- 1:01Speaker 2: Clearway Health streamlines the entire medication journey, ensuring patients receive
- 1:06Speaker 2: the right medications at the right time. Clearway Health brings
- 1:09Speaker 2: real-world experience and proven results, helping health systems unlock new
- 1:14Speaker 2: revenue streams while expanding access to life-changing specialty medications. Clearway
- 1:19Speaker 2: Health is leading the way in transforming specialty pharmacy. Learn
- 1:23Speaker 2: more at clearwayhealth.com. You are listening to the global network
- 1:36Speaker 2: of podcasters dedicated to the pharmacy profession.
- 1:39Speaker 3: Welcome to the Pharmacy Podcast Network.
- 1:55Speaker 4: It's that time of year where the Pharmacy Podcast Network's
- 1:58Speaker 4: founder and CEO, Todd Ury, lands where the hub of
- 2:02Speaker 4: specialty pharmacy hosts.
- 2:03Speaker 5: Their annual meeting.
- 2:06Speaker 4: Introducing the Inspire 2026 Annual Expo.
- 2:10Speaker 2: That's right.
- 2:11Speaker 4: Specialty pharmacy is evolving, and so is the name of
- 2:14Speaker 4: its largest annual meeting. The NASP Annual Meeting and Expo
- 2:18Speaker 4: got an upgrade. Innovation, networking, specialty pharmacy expertise. insights, research,
- 2:25Speaker 4: and education come together to empower, educate, and connect our community.
- 2:30Speaker 4: Live in National Harbor, Maryland, tune in as Todd roams
- 2:34Speaker 4: the showroom floor, bringing you the inside coverage of this
- 2:37Speaker 4: year's event.
- 2:41Speaker 5: Richard Brook, back on the pods, NASP podcast. Richard, this
- 2:45Speaker 5: is becoming a tradition for us.
- 2:48Speaker 6: One of the better traditions in my life, Todd. You
- 2:51Speaker 6: and the podcast, great. information dissemination vehicle and number one
- 2:58Speaker 6: in the industry supporting a really growing industry and a
- 3:02Speaker 6: growing meeting. We were just talking earlier about how this
- 3:06Speaker 6: is the NAS meeting and we started in 2013. Yeah,
- 3:10Speaker 6: this is nuts. Number 14. And, you know, I know
- 3:15Speaker 6: you weren't at some of the early meetings, but some
- 3:18Speaker 6: of the early meetings were a bunch of us in
- 3:20Speaker 6: a small room.
- 3:21Speaker 7: Right.
- 3:22Speaker 6: And I remember one of the early meetings, we had
- 3:26Speaker 6: three posters. And I kind of took it on myself
- 3:29Speaker 6: to work with the NASP Education Committee to see how
- 3:32Speaker 6: we can grow this program. And if you look at
- 3:35Speaker 6: the poster hall today, and I know the audience can't
- 3:37Speaker 6: see it, but if you have access to the NASP website,
- 3:40Speaker 6: most of the posters are published. And in fact, we
- 3:43Speaker 6: actually publish them in a supplement to CMRO. So that
- 3:47Speaker 6: is open access that just about anybody can get to.
- 3:49Speaker 6: And We have about 140 posters today, which just the
- 3:55Speaker 6: growth has been incredible. And walking through the posters today,
- 4:00Speaker 6: I'm just amazed at how we showcase what specialty pharmacy
- 4:05Speaker 6: is doing for the world. People don't think about it,
- 4:09Speaker 6: but we know these drugs are high touch. They require
- 4:12Speaker 6: special handling prior auth and a whole process. And the
- 4:17Speaker 6: various vendors here at the meeting have been showcasing Their
- 4:21Speaker 6: SPs get it done. And I was reviewing posters earlier
- 4:25Speaker 6: today as part of the judging process, and I was
- 4:28Speaker 6: amazed at some of.
- 4:29Speaker 8: The techniques I've seen.
- 4:31Speaker 6: Because, you know, if you're a cardiovascular company or a
- 4:35Speaker 6: hepatitis company, you go to the clinical meetings on those.
- 4:38Speaker 6: But if you're a specialty pharmacy, and let's say you
- 4:41Speaker 6: handle different drugs and different therapeutic areas, there really is
- 4:45Speaker 6: no forum to showcase what you do.
- 4:49Speaker 8: That's where NASP kind.
- 4:50Speaker 6: Of really is strong because, you know, Sheila and the
- 4:53Speaker 6: whole NASP education committee have been really good at building
- 4:56Speaker 6: out the educational component of this meeting.
- 4:59Speaker 8: We teach, we learn, we grow together.
- 5:03Speaker 6: And so the growth of the abstract program kind of
- 5:06Speaker 6: exemplifies that.
- 5:08Speaker 5: That's incredible. So, Richard, has there been any posters, without
- 5:12Speaker 5: being specific to the developer, that have stuck out to
- 5:16Speaker 5: you based on innovation of specialty pharmacy?
- 5:20Speaker 6: You know, I've seen a lot of posters talking about
- 5:23Speaker 6: how they're integrating AI into their business models, how they're
- 5:27Speaker 6: shortening time to approval. You know, you can have the
- 5:31Speaker 6: best drug in the world, but if it can't get
- 5:33Speaker 6: to your patient, it's never going to treat them.
- 5:36Speaker 8: And then we also see a lot of things.
- 5:38Speaker 6: Talking about how they provide copay assistance and they help
- 5:42Speaker 6: get the patient through the hurdle of onboarding and they
- 5:46Speaker 6: manage side effects, and they reduce problems, hospitalizations. So a
- 5:52Speaker 6: lot of things that happen behind the scenes that you
- 5:56Speaker 6: never really understand until you're a patient, or perhaps you
- 6:00Speaker 6: see it being presented at a meeting like this.
- 6:03Speaker 5: I appreciate that. So if I'm listening to the show,
- 6:06Speaker 5: and I didn't get a chance to come to the
- 6:09Speaker 5: Inspire 2026 event, And I thought, hey, I have some research.
- 6:15Speaker 5: I have something that I've worked on. How do I
- 6:17Speaker 5: get involved in submission of a poster? Oh, great question, Todd.
- 6:21Speaker 6: So we have a very active education committee and a
- 6:24Speaker 6: poster and abstract committee through Inspire.
- 6:26Speaker 8: Now, Inspire is the name of the meeting.
- 6:28Speaker 9: Yep.
- 6:28Speaker 8: But NASP is the name of the organization.
- 6:30Speaker 10: Right.
- 6:31Speaker 6: And it's NASP, specialty pharmacy, because there's a couple of
- 6:33Speaker 6: other NASPs out there in the world. So if you
- 6:36Speaker 6: go onto the website, you'll generally see around January of
- 6:39Speaker 6: the year, that we put out our call for abstracts.
- 6:43Speaker 6: You don't have to be a NASP member to submit
- 6:45Speaker 6: an abstract. And we've got a great review team. You
- 6:49Speaker 6: go through it. If your abstract needs a little fine tuning,
- 6:52Speaker 6: we'll actually tell you, you know, we think your abstract
- 6:55Speaker 6: could be strengthened by this. And unlike a lot of
- 6:58Speaker 6: other meetings, NASP actually provides continuing education credit for reviewing
- 7:03Speaker 6: the posters.
- 7:04Speaker 8: So it's a great thing.
- 7:06Speaker 6: When I got involved with this, I searched out all
- 7:09Speaker 6: the different journals to see who would be willing to
- 7:12Speaker 6: work with us. And we were very lucky to form
- 7:14Speaker 6: a relationship with the people.
- 7:16Speaker 8: At Taylor and Francis.
- 7:17Speaker 6: And they shifted from the original journal we were in
- 7:22Speaker 6: to current medical research and opinion about five years ago.
- 7:26Speaker 6: And all the posters are available, the abstracts there, the
- 7:31Speaker 6: I'm not sure if CMRO is publishing the poster, but
- 7:34Speaker 6: the NASP website actually presents and publishes the poster as well.
- 7:39Speaker 5: Richard, you've been a special part of the NASP for years.
- 7:43Speaker 5: I just want to say thank you for your work.
- 7:46Speaker 5: I also want to say thank you for being on
- 7:47Speaker 5: the show and being a consistent beacon of what's happening
- 7:51Speaker 5: in our profession, especially from the poster perspective. But thank you.
- 7:55Speaker 6: And thank you for everything that you do in terms
- 7:57Speaker 6: about being a beacon and a point of light and
- 8:00Speaker 6: a source of information. You know, I think I wouldn't
- 8:03Speaker 6: be doing my company, I'd be doing a disservice if
- 8:07Speaker 6: I didn't mention what we were talking about in our
- 8:09Speaker 6: poster today. Because, you know, we take a look at
- 8:12Speaker 6: it from a different perspective than a lot of the
- 8:14Speaker 6: other companies. We're not a specialty pharmacy. Better Health Worldwide
- 8:18Speaker 6: is a research organization. And what we actually are presenting
- 8:22Speaker 6: is a poster looking at women who have infertility issues.
- 8:28Speaker 6: And we looked at all of our employers that were
- 8:30Speaker 6: covering it to see how rich the fertility benefit is. Now,
- 8:35Speaker 6: the government right now is talking about wanting to increase
- 8:39Speaker 6: the fertility benefit for all.
- 8:41Speaker 9: The U.S.
- 8:42Speaker 6: Is falling behind on a world level. We don't have
- 8:45Speaker 6: the population growth that some people would like to see.
- 8:48Speaker 9: Right.
- 8:49Speaker 8: And that's for a variety of reasons. And I don't
- 8:51Speaker 8: want to get into the politics of it.
- 8:53Speaker 6: However, every company that says they have benefit information generally
- 8:58Speaker 6: just has you have medical.
- 9:00Speaker 8: Coverage or you have prescription coverage. We actually worked.
- 9:03Speaker 6: With our account managers to go back, look at the
- 9:06Speaker 6: individual employers, and they're all self-insured, so they're paying for everything,
- 9:11Speaker 6: and see how rich the fertility benefit is. Some companies
- 9:14Speaker 6: had annual benefits. Some had maximum benefits for a lifetime.
- 9:18Speaker 6: Some had three rounds of IVF lifetime. And when we
- 9:22Speaker 6: look at that and we look at some of the
- 9:23Speaker 6: proposed policies, most of our employer benefits today are below
- 9:29Speaker 6: the proposed threshold.
- 9:30Speaker 8: So it'll be very interesting to see what happens.
- 9:33Speaker 6: Government speak to become government action are two different things,
- 9:36Speaker 6: but it'd be very interesting to see over time how
- 9:39Speaker 6: rich that benefit is, if it ever is enhanced. And,
- 9:43Speaker 6: you know, we have a lot of things going on
- 9:44Speaker 6: in our country, a lot of things in our healthcare system.
- 9:47Speaker 6: The goal in life, it really is to make it
- 9:50Speaker 6: a better place right now and to have better health
- 9:53Speaker 6: for everybody. And that's why we named our company Better
- 9:56Speaker 6: Health Worldwide.
- 9:57Speaker 5: I love it. Thank you, Richard, and Brooke, for being
- 10:00Speaker 5: on the show. We look forward to talking to you again.
- 10:03Speaker 5: NASP 2027.
- 10:04Speaker 9: Thanks, Todd. See you.
- 10:12Speaker 5: Robert, welcome to the show. Thanks for being on the
- 10:14Speaker 5: NASP podcast here at Inspire 2026. Thank you, Todd.
- 10:18Speaker 9: Appreciate it.
- 10:19Speaker 5: So First Data Bank has been a big supporter of
- 10:22Speaker 5: the Pharmacy Podcast Network. We worked with you at the
- 10:24Speaker 5: NACDS Total Store Expo. It was wonderful. And that was
- 10:28Speaker 5: a very different tempo. It was a different environment. than
- 10:34Speaker 5: the intensity of specialty pharmacy in comparison. I want to
- 10:38Speaker 5: talk to you today about a special sector of specialty
- 10:41Speaker 5: pharmacy that we're very concerned with on our publication. We
- 10:45Speaker 5: have a series coming out called Specialty Care Close to Home,
- 10:48Speaker 5: and it's focusing on the build-out, the improvement, and the
- 10:53Speaker 5: running of health system pharmacies that have specialty pharmacies implanted
- 10:58Speaker 5: into them. FDB has a special service that focuses on
- 11:03Speaker 5: the support of our hospital system specialty pharmacies. Talk to
- 11:07Speaker 5: our listeners about that.
- 11:09Speaker 3: Yeah, with FDB, we work with.
- 11:11Speaker 11: Compass Rose, so integrating with Epic and with Compass Rose
- 11:15Speaker 11: and just helping them with the content and with the
- 11:17Speaker 11: flow sheets, the monographs there, and the referential guides to
- 11:22Speaker 11: make sure that they're able to assess with their patients
- 11:25Speaker 11: as they're coming through this hard hardship of oncology or
- 11:29Speaker 11: any type of cancer or there are high cost medications
- 11:32Speaker 11: of these difficult with the specialty pharmacy.
- 11:34Speaker 5: What kind of education is ongoing and explaining to the
- 11:39Speaker 5: hospital system pharmacy of what opportunities they have to engage
- 11:44Speaker 5: FDB and use FDB as a conduit and as a partner?
- 11:49Speaker 8: It comes to the buy versus build.
- 11:51Speaker 11: So if you want to build it yourself within Compass
- 11:54Speaker 11: Rose or within your own specialty pharmacy, you can go
- 11:58Speaker 11: ahead and do that. But with FDB, we help you,
- 12:01Speaker 11: guide you through this, give you the content, able to
- 12:04Speaker 11: work with our team and.
- 12:08Speaker 5: I guess work with our team to educate.
- 12:10Speaker 11: You and help make sure that your assessments, customize your
- 12:12Speaker 11: assessments so you're not always doing redundant things or repeating
- 12:16Speaker 11: things when you get those monthly loads or the monthly
- 12:20Speaker 11: things that come through Compass Rose or even come through
- 12:22Speaker 11: your own content yourself.
- 12:25Speaker 5: Okay. And then FDB has to be working with an
- 12:29Speaker 5: API or some mechanism to communicate with the health record
- 12:34Speaker 5: or the health electronic record. It might be Epic or
- 12:37Speaker 5: something else. Talk to me about that component of working
- 12:40Speaker 5: with health system pharmacies.
- 12:42Speaker 11: Yeah, so we came up with a lot of when
- 12:44Speaker 11: it comes to redundancy of like, hey, we are doing
- 12:49Speaker 11: this over and over again. And your content is not
- 12:52Speaker 11: really working for us or we have to feel that
- 12:55Speaker 11: we are building it ourselves. So we came up with
- 12:58Speaker 11: our new component called Specialties Space.
- 13:02Speaker 8: And specialty space.
- 13:03Speaker 11: Is a UL component that we are able to customize
- 13:07Speaker 11: before you get those loads from us or before you
- 13:11Speaker 11: load it into your Epic Compass Rose. So you're able
- 13:14Speaker 11: to customize governance, go over your disease states, go over
- 13:17Speaker 11: all your medications, and specialize in. And we also have
- 13:21Speaker 11: the URAC, who's here today. So yeah, so you have
- 13:24Speaker 11: all those accreditations.
- 13:27Speaker 9: For the URAC there.
- 13:28Speaker 5: That's incredible. We appreciate not only FDB support, but the
- 13:32Speaker 5: intelligence that you're bringing to different facets of pharmacy. Here
- 13:36Speaker 5: in specialty, it's so needed because of the complexity of
- 13:39Speaker 5: disease state management. I want to thank you for being
- 13:42Speaker 5: on the NASP podcast.
- 13:43Speaker 3: Thank you.
- 13:44Speaker 9: I appreciate it, Todd.
- 13:44Speaker 3: Thank you.
- 13:47Speaker 10: Healthcare innovation moves quickly, but innovation is only valuable when
- 13:52Speaker 10: clinicians can trust the information behind it. That is where FDB,
- 13:56Speaker 10: or First Data Bank, makes the difference. FDB provides trusted,
- 14:00Speaker 10: clinically validated medication knowledge and clinical decision support designed for
- 14:04Speaker 10: integration into modern healthcare technology. From electronic health records and
- 14:08Speaker 10: pharmacy systems to e-prescribing networks, artificial intelligence, payer platforms, and
- 14:13Speaker 10: patient-facing solutions, FDB helps turn complex drug data into actionable guidance.
- 14:19Speaker 10: FDB is also advancing the future of medication intelligence by
- 14:23Speaker 10: enabling AI-powered workflows to draw from reliable, expert-curated clinical content,
- 14:28Speaker 10: helping technology move beyond information towards safer, more useful action.
- 14:33Speaker 10: For pharmacists and clinicians, that means more relevant medication alerts,
- 14:37Speaker 10: stronger clinical decision support, improved reconciliation, clearer patient instructions, and
- 14:42Speaker 10: information that fits naturally into the workflow. For healthcare technology companies,
- 14:47Speaker 10: it means access to proven drug knowledge that can strengthen products,
- 14:50Speaker 10: support responsible innovation, and improve the decisions made at every
- 14:54Speaker 10: point of care. Learn how FDB is connecting trusted drug knowledge,
- 14:58Speaker 10: intelligent technology, and patient-centered care. Visit fdbhealth.com. First Data Bank,
- 15:04Speaker 10: powering the medication decisions that move healthcare forward every single day, worldwide.
- 15:22Speaker 5: The aspect of specialty pharmacy and what it means from
- 15:27Speaker 5: a technological perspective is all about workflow. It's all about
- 15:31Speaker 5: being able to do things in the process. of getting
- 15:35Speaker 5: the prior authorization handled ahead of time and getting obstacles
- 15:39Speaker 5: out of the way for the prescriber and handing it
- 15:42Speaker 5: off to the right pharmacy for the right reasons. I'm
- 15:46Speaker 5: here with Sam Bajor with Inovalon to talk more about workflow. Sam,
- 15:51Speaker 5: welcome to the show.
- 15:53Speaker 3: Thank you, Todd.
- 15:54Speaker 5: So the NASB podcast has been part of the Pharmacy
- 15:56Speaker 5: Podcast Network for about six or seven years. This is
- 16:00Speaker 5: our first time that we get to celebrate and inspire
- 16:02Speaker 5: here at 2026. We've been watching Inovalon grow over the years.
- 16:07Speaker 5: You guys are doing some exceptional work. Talk to me
- 16:10Speaker 5: about how Inovalon removes those kinds of barriers that we
- 16:13Speaker 5: just discussed and how workflow flows better based on Inovalon's infrastructure.
- 16:19Speaker 12: Sure.
- 16:19Speaker 5: Thank you, Todd.
- 16:21Speaker 13: When I think of what Inovalon has done to make
- 16:23Speaker 13: the workflow better in a specialty pharmacy, I think of
- 16:27Speaker 13: two things. I think of skilling and driving the right
- 16:31Speaker 13: work to the right users from a skill perspective.
- 16:35Speaker 3: It's not just one workflow where.
- 16:38Speaker 13: Mary has to do the same thing that Todd does,
- 16:42Speaker 13: but Mary may not have the skill to.
- 16:44Speaker 3: Do the same thing that Todd does.
- 16:46Speaker 13: We can drive the right work based on that person's
- 16:52Speaker 13: skill to get the job done much smoother and easier.
- 16:56Speaker 13: And two, we have a considerable amount of configurability. There
- 17:03Speaker 13: are differences based on drugs, based on disease state, what
- 17:08Speaker 13: is required to complete the workflow based on a drug
- 17:13Speaker 13: or a disease state. What we have done is provide
- 17:17Speaker 13: our businesses the capability to own that themselves and not
- 17:23Speaker 13: require opening a ticket with a vendor to create a
- 17:26Speaker 13: whole new workflow that takes three months to implement. We've
- 17:30Speaker 13: given them the tools to do that themselves. So when
- 17:34Speaker 13: a new product comes out and it requires some special
- 17:38Speaker 13: data collect or a new assessment to be completed, they
- 17:42Speaker 13: can do that in a much shorter period of time.
- 17:46Speaker 5: Sam, talk to me about how you're making it easier
- 17:49Speaker 5: for the manufacturer to do business with my specialty pharmacy
- 17:54Speaker 5: from an API perspective, from gathering REMS information. Talk to
- 17:59Speaker 5: me about that side of it.
- 18:00Speaker 3: Sure.
- 18:02Speaker 13: We'll talk about structured data, whether that's where a referral
- 18:08Speaker 13: or an order is within the workflow. Look, pharma wants
- 18:13Speaker 13: to know where those orders are, right? We want to
- 18:17Speaker 13: get patients on medication faster. Everybody wins when we do that.
- 18:23Speaker 13: So what we've done at Inovalon is make sure that
- 18:26Speaker 13: those orders Even the statuses. I mean, everybody, I think,
- 18:30Speaker 13: can take and report on things that have shipped.
- 18:35Speaker 9: Yeah.
- 18:35Speaker 7: Right?
- 18:36Speaker 13: But when you talk about where an order or a
- 18:39Speaker 13: referral is within the workspace and within the workflow, you're
- 18:43Speaker 13: talking about having structured statuses and even substatuses in some
- 18:47Speaker 13: cases to determine and report where something is.
- 18:53Speaker 8: That's where Novolon.
- 18:54Speaker 3: Has taken it to the next level. I love it.
- 18:57Speaker 7: All right.
- 18:58Speaker 5: I'm a specialty pharmacy. I'm focused on blood disorders, hyperlipidemia
- 19:04Speaker 5: or something. I have a bucket of patients. How am
- 19:07Speaker 5: I communicating with my patient through Inovalon? How am I
- 19:10Speaker 5: engaging and keeping them tied into us?
- 19:13Speaker 3: Variety of different ways.
- 19:15Speaker 13: Obviously, everybody wants to have some sort of digital capability.
- 19:18Speaker 12: Yeah.
- 19:19Speaker 13: Whether that means you're texting patients, everybody's calling them, but
- 19:24Speaker 13: we've extended our product through a patient portal as well.
- 19:29Speaker 13: And I always like to use an example of a
- 19:32Speaker 13: product that Has a significant side effect. Look, a lot
- 19:37Speaker 13: of the specialty drugs, while they're treating unique diseases, but
- 19:41Speaker 13: they all oftentimes come with special side effects that specialty
- 19:45Speaker 13: pharmacies and pharmacists have to help manage those patients through.
- 19:50Speaker 9: That.
- 19:51Speaker 3: Once they get.
- 19:51Speaker 13: Past that, they can stay on therapy. A good example
- 19:55Speaker 13: of this is you dispense a product. It causes a
- 20:00Speaker 13: significant amount of diarrhea in a significant percentage of patients.
- 20:05Speaker 5: Ten days later, it's very important.
- 20:07Speaker 13: That you follow up with that patient to make sure
- 20:09Speaker 13: they're getting past that.
- 20:11Speaker 5: Yeah, because they went off the med. They're like, get
- 20:13Speaker 5: me off this med. I have diarrhea every damn day.
- 20:15Speaker 3: Every day.
- 20:16Speaker 7: Yep.
- 20:16Speaker 13: So one of the nice things about our product is
- 20:19Speaker 13: you can extend that assessment to the patient portal, and
- 20:23Speaker 13: they can complete that process.
- 20:25Speaker 1: From a text message that we've.
- 20:26Speaker 13: Sent to them, they can go online and complete that
- 20:30Speaker 13: assessment to help them through these things. Or, obviously, they
- 20:35Speaker 13: can connect to a pharmacist to talk them through that.
- 20:38Speaker 13: And we create a workflow so that it doesn't get lost.
- 20:42Speaker 13: It's not just, oh, I sent a text message, and
- 20:44Speaker 13: I don't know if Mary Jones answered it.
- 20:46Speaker 9: Right.
- 20:47Speaker 13: It's traceable and trackable. So I think that's one of
- 20:52Speaker 13: the ways we connect with our specialty patients.
- 20:56Speaker 14: All right.
- 20:56Speaker 5: Last question. Let's talk about financial reporting. I'm a specialty pharmacy.
- 21:02Speaker 5: I have hub relationships with my manufacturers. I have reporting
- 21:06Speaker 5: I need to do. But comes down to that bottom
- 21:10Speaker 5: line and me getting paid to keep my operations going.
- 21:13Speaker 5: Talk to me about the reports that are available through
- 21:16Speaker 5: Novolon for finances.
- 21:18Speaker 13: For Novolon, the ScriptMed product itself comes with a suite
- 21:22Speaker 13: of about 40, I'm rounding, I think it's 39 exactly,
- 21:28Speaker 13: but out-of-the-box dashboards. And that goes from referral side through RCM.
- 21:36Speaker 7: Okay.
- 21:37Speaker 13: So you have a visual of where things are, what's
- 21:42Speaker 13: been dispensed, the margin associated with those dispenses. And then
- 21:48Speaker 13: when it comes to reporting those things, again, it's structured data.
- 21:53Speaker 5: You can export any of those reports.
- 21:56Speaker 13: We even have a product where we'll take that data
- 22:01Speaker 13: and you can– send that into your sort of database,
- 22:06Speaker 13: whether that's a version of Snowflake or something similar, where
- 22:10Speaker 13: you can do your own queries.
- 22:12Speaker 3: Off of that.
- 22:13Speaker 13: So that's a product that we feel very strongly about,
- 22:17Speaker 13: where we give people all access to all their data
- 22:22Speaker 13: so they can do what they want with it.
- 22:24Speaker 5: Yeah, and the interpretation of the data is just as
- 22:27Speaker 5: important as the data itself. Because if you just give
- 22:29Speaker 5: me a bunch of data, I'm not going to know
- 22:31Speaker 5: what to do with it.
- 22:32Speaker 9: Right.
- 22:32Speaker 13: Obviously, it comes with a suite of data dictionaries to
- 22:36Speaker 13: tell you what each of them mean.
- 22:38Speaker 5: That's excellent. Sam, this has been great. I appreciate you
- 22:41Speaker 5: jumping on the NASP podcast here at Inspire 2026. We
- 22:46Speaker 5: look forward to seeing you in Orlando in 2027. Thank
- 22:48Speaker 5: you for having me, Todd.
- 22:49Speaker 3: Thank you.
- 22:54Speaker 5: JB Consulting, Sean Jensen. It's Inspire 2026 in Washington, D.C.
- 23:02Speaker 5: Welcome to the NASP podcast.
- 23:04Speaker 3: Thanks for having me, Todd. Great to see you as always.
- 23:06Speaker 5: How many NASP podcasts is this for you?
- 23:09Speaker 3: I don't know. I think four, something like that. Four, five, six.
- 23:12Speaker 3: I always try to come by.
- 23:13Speaker 5: I'm not sure.
- 23:14Speaker 3: No, I love it.
- 23:16Speaker 5: I have become a friend of yours. The friendship means
- 23:19Speaker 5: a lot to me. I love watching your career. I
- 23:23Speaker 5: love thinking of the impact that you've had on the profession,
- 23:27Speaker 5: specifically specialty. You've had influence on other people in development
- 23:33Speaker 5: of programs and the use of AI. I've watched your
- 23:37Speaker 5: interaction on LinkedIn. You're very professional. you're a giver. You're
- 23:42Speaker 5: not someone that constantly takes, and we need more of that,
- 23:45Speaker 5: especially in specialty. We need that guidance. Give us an update.
- 23:50Speaker 5: Give our listeners an update. What is JB Consulting? Why
- 23:53Speaker 5: are you involved with NASP? Why is it important to
- 23:56Speaker 5: be here as a technologist?
- 23:59Speaker 15: I mean, if you're in specialty pharmacy in any capacity,
- 24:01Speaker 15: I mean, this is certainly the place to be. This
- 24:03Speaker 15: is the world headquarters, I like to think, of the
- 24:06Speaker 15: specialty pharmacy industry. Um, This is one of my favorite
- 24:09Speaker 15: events of the year, too, and I love this group.
- 24:12Speaker 15: It holds a close place to my heart. I mean,
- 24:15Speaker 15: they've changed the name to Inspire this year, you know,
- 24:17Speaker 15: partly to show it's not just a meeting every year.
- 24:20Speaker 3: It's not just a networking event.
- 24:21Speaker 15: It's, like, all the things NASP does throughout the year
- 24:23Speaker 15: that are so important. And, you know, there's a lot
- 24:25Speaker 15: of education, obviously. There's inspiration. That's where the name's coming from.
- 24:29Speaker 15: And within our tech committee, which I invite anybody listening
- 24:32Speaker 15: to join, reach out to me if you want to
- 24:34Speaker 15: join it. It's just such a great knowledge share of
- 24:37Speaker 15: professionals and information. Like you said, I try to be
- 24:41Speaker 15: a giver.
- 24:41Speaker 3: I appreciate you saying that.
- 24:43Speaker 15: I feel like the membership here, too, everyone.
- 24:45Speaker 3: Wants to help each other out.
- 24:47Speaker 15: If you come from a deep profession where you have
- 24:50Speaker 15: a lot of experience to share, great. If you just
- 24:52Speaker 15: want to learn, it's just as welcome. We really take
- 24:55Speaker 15: anybody over there. I feel like that represents the industry
- 24:58Speaker 15: as a whole, too.
- 25:00Speaker 5: I remember, I'm old enough to say this, but the
- 25:02Speaker 5: buzzword Between 99 and 2003 was internet, e-commerce, website development.
- 25:12Speaker 5: That was like the trend back then. And people were confused.
- 25:16Speaker 5: How am I going to use this thing called the
- 25:19Speaker 5: magic interweb to do things in my business? Well, we
- 25:24Speaker 5: jettison ahead. Today's key word is AI, artificial intelligence. And
- 25:30Speaker 5: it's interesting. I see contrasts. in overshooting, overusage, misusage, hallucination,
- 25:39Speaker 5: things that are happening that I remember back in 99
- 25:41Speaker 5: to 2003 in the use of the internet into business.
- 25:46Speaker 5: and now it's even more complex in the use of
- 25:49Speaker 5: healthcare and, of course, in our space in specialty pharmacy.
- 25:53Speaker 5: Give us kind of like, I mean, this could be
- 25:55Speaker 5: a whole podcast in itself that would be a Joe
- 25:57Speaker 5: Rogan-style two-hour show, but give us your high level of
- 26:02Speaker 5: where are we with the command of AI in specialty pharmacy.
- 26:07Speaker 15: I mean, AI has gone so quickly with, I mean,
- 26:11Speaker 15: everyone knows that, but I guess two years ago, I
- 26:13Speaker 15: thought the technology day, whatever it.
- 26:15Speaker 3: Was called back then, Yeah. It's a different name each year.
- 26:19Speaker 15: But we asked the survey, like, raise your hand if you're,
- 26:22Speaker 15: what you're doing with AI.
- 26:22Speaker 3: And nobody had launched anything. Nobody had piloted anything.
- 26:25Speaker 15: 100% of the people were interested in doing something, but
- 26:29Speaker 15: nobody had taken action yet. And I think they were
- 26:31Speaker 15: kind of waiting to see. And then they asked the
- 26:32Speaker 15: same question yesterday. And zero people had done nothing. Zero
- 26:37Speaker 15: people were on the sideline. Everyone had done something. And
- 26:39Speaker 15: more than half had launched a pilot or were.
- 26:41Speaker 3: Actually in production. I don't know. Maybe some people just
- 26:43Speaker 3: didn't want to put their hand up and say they
- 26:44Speaker 3: did nothing. That's probably more realistic.
- 26:46Speaker 12: Yeah.
- 26:47Speaker 15: But everyone's doing something. And it seems like a lot
- 26:50Speaker 15: of talk of KPIs. I mean, now that some time
- 26:52Speaker 15: has passed, people are really looking at how do you
- 26:54Speaker 15: measure not just the efficiency of your cost to fill,
- 26:58Speaker 15: your time to fill, things like that, but the quality.
- 27:02Speaker 15: Has it made things better? Obviously, it's making it faster,
- 27:05Speaker 15: but the impact on quality. And also capacity. There's a
- 27:10Speaker 15: lot of talk of AI's creating this new capacity. So
- 27:14Speaker 15: rather than taking jobs, it's freeing up time to do
- 27:18Speaker 15: things that pharmacists want to do, which has always been, you.
- 27:20Speaker 3: Know, the goal and what people hope would happen.
- 27:23Speaker 15: I mean, I kind of wonder, I guess the question
- 27:25Speaker 15: would be like, there's only so much capacity and you
- 27:28Speaker 15: can take referrals from the companies who are falling behind
- 27:31Speaker 15: and not keeping up with AI. But at some point,
- 27:33Speaker 15: you know, it's going to hit the wall and then,
- 27:36Speaker 15: you know, you've saved headcount and what are you going
- 27:38Speaker 15: to do with that? So, I mean, I'm kind of
- 27:41Speaker 15: pessimistic that there's still going to be Some AI taking
- 27:44Speaker 15: over some pharmacy jobs at some point. We're still in
- 27:47Speaker 15: that early stage where, like I said, it improves capacity
- 27:51Speaker 15: so you can win some more referrals and grow your business.
- 27:53Speaker 15: But it's hard to see that continuing as everyone kind
- 27:57Speaker 15: of gets these tools to start using them. But it's
- 28:00Speaker 15: a really exciting time for people that are using it
- 28:02Speaker 15: and the health systems and the pharmacies who are adopting it.
- 28:04Speaker 15: I mean, they're seeing just crazy improvements across the board.
- 28:09Speaker 5: I'm hearing... Not as many horror stories as I'm hearing
- 28:14Speaker 5: success stories, but there are crash and burn stories out
- 28:19Speaker 5: there where you'll have a very innovative, aggressive business owner,
- 28:24Speaker 5: could be a pharmacist, doesn't have to be, where I've
- 28:27Speaker 5: heard them trying to take AI and trying to do
- 28:31Speaker 5: it themselves as an amateur. And that's where I've talked
- 28:36Speaker 5: with these professional programmers who who were doing coding 20
- 28:42Speaker 5: years ago when SQL Server was.
- 28:45Speaker 3: A big deal.
- 28:46Speaker 5: And now you put AI on top of the mature
- 28:49Speaker 5: veteran in the technology development space. That is a different
- 28:55Speaker 5: world and universe than the amateur. But you know what?
- 28:58Speaker 5: AI has encouraged the amateur to rise. And they're overshooting.
- 29:05Speaker 5: They don't know of the security and the cybersecurity issues
- 29:08Speaker 5: that are being created. Talk to me about some of,
- 29:12Speaker 5: you don't have to name names, but talk to me
- 29:14Speaker 5: about some of those red flags that AI have brought
- 29:17Speaker 5: to the entrepreneur and the aggressiveness of using it.
- 29:22Speaker 15: I mean, I guess I love the innovation that people
- 29:25Speaker 15: are trying to do all these things.
- 29:27Speaker 3: I think there's some false confidence.
- 29:28Speaker 15: I mean, the difference between a demo and a prototype
- 29:32Speaker 15: and something that's actually like production enterprise ready and live,
- 29:35Speaker 15: especially in something as important as healthcare.
- 29:37Speaker 3: I mean, that contrast has been there for as long
- 29:40Speaker 3: as we've been around.
- 29:40Speaker 15: I mean, you see smoke and mirror demos, but with AI,
- 29:43Speaker 15: I mean, you can make one of those demos in
- 29:45Speaker 15: five minutes, come here and start showing it and show
- 29:48Speaker 15: what it can do. And I mean, whether or not
- 29:50Speaker 15: that's going to work in the real world remains to
- 29:52Speaker 15: be seen for a lot of those companies. But Just
- 29:54Speaker 15: even with some guidance and some expert help, the expert
- 29:58Speaker 15: doesn't have to do it. I think people get this
- 30:02Speaker 15: sense of confidence that they can do it themselves, which
- 30:05Speaker 15: it feels like they can. And it's not that they
- 30:07Speaker 15: need someone else to come in and do it for them.
- 30:09Speaker 15: They just might need some guidance, someone who's been there before,
- 30:11Speaker 15: someone who's seen what can happen to go in and
- 30:14Speaker 15: just make sure they're not doing something crazy.
- 30:16Speaker 3: And, you know, you don't want to get.
- 30:17Speaker 15: Yourself in the news for rushing something out the door
- 30:20Speaker 15: and all of a sudden, you know, all things are compromised.
- 30:22Speaker 5: HIPAA violation everywhere.
- 30:23Speaker 3: Left and right, yeah.
- 30:24Speaker 15: So, I mean, AI is a tool like anything else
- 30:27Speaker 15: and needs to be used responsibly and, you know, the
- 30:30Speaker 15: right way.
- 30:31Speaker 5: It's helped your organization, obviously. So what's JB Consulting doing
- 30:36Speaker 5: with AI right now to really help jump and make
- 30:40Speaker 5: programming happen quicker than what it was?
- 30:43Speaker 15: Yeah, I mean, our programming team, they're using it. Just
- 30:47Speaker 15: like most development teams, it saves a lot of time.
- 30:50Speaker 15: But the same way you obviously can't just ask it
- 30:53Speaker 15: to write some code and copy and paste it in,
- 30:55Speaker 15: I mean, unless.
- 30:55Speaker 3: You're asking for security problems.
- 30:56Speaker 15: You know, that's kind of what the whole thing with AI,
- 30:59Speaker 15: like it can help move things quicker and it can
- 31:01Speaker 15: help you prototype.
- 31:02Speaker 3: And it can do a lot.
- 31:03Speaker 15: You just need somebody in the chain that knows what's
- 31:05Speaker 15: going on. the same way if you had a junior
- 31:07Speaker 15: programmer like you wouldn't necessarily have them writing code and
- 31:10Speaker 15: like hey an hour later it's in production like right
- 31:13Speaker 15: slow down see what they're doing the same thing you
- 31:14Speaker 15: do with ai so i mean i see within our
- 31:17Speaker 15: group we're still also focused on you know research and
- 31:21Speaker 15: we're helping other companies kind of use ai to force
- 31:24Speaker 15: multiply things that they would be doing i mean there's
- 31:26Speaker 15: a lot of companies doing automation we're not necessarily doing
- 31:29Speaker 15: that right now but we are helping people select vendors
- 31:32Speaker 15: that would be the best ones to do so knowing
- 31:34Speaker 15: who to trust and who's been around and kind of
- 31:36Speaker 15: helping vet out some of these vendors that are out here.
- 31:39Speaker 3: We've been doing a.
- 31:39Speaker 15: Lot with that, but AI ourselves, I mean, we're doing
- 31:42Speaker 15: a lot, like I said, research and just force multiplying.
- 31:46Speaker 5: So, Sean, you and I are basically sharing with the
- 31:49Speaker 5: listeners the exact same scenarios that a pharmacist who has
- 31:55Speaker 5: to do, they're using their license to push a product
- 32:00Speaker 5: out to the patient, and it's their responsibility to And
- 32:05Speaker 5: we say the same thing to them. Hey, AI is wonderful.
- 32:10Speaker 5: Go ahead and merge it or plug it into your
- 32:12Speaker 5: MediSpan database. Let's get it to kind of think forward.
- 32:16Speaker 5: Predictive modeling becomes real. However, it comes back to the
- 32:21Speaker 5: pharmacist as the clinical leader and medication leader to say,
- 32:25Speaker 5: at the end, I'm going to still check this work.
- 32:28Speaker 5: I'm going to still check this And this information, just
- 32:33Speaker 5: as if it were a pharmacy tech that was helping
- 32:35Speaker 5: me push this prescription through the process, you can't rely
- 32:40Speaker 5: on that as the end all be all. And I
- 32:43Speaker 5: would think ever. I mean, I don't care how great
- 32:46Speaker 5: AI becomes someday, 10 years from now. it's still going
- 32:49Speaker 5: to come back to the human DEA slash license individual
- 32:57Speaker 5: to have the final say. It's your license. It's your responsibility.
- 33:01Speaker 3: Yeah, it's a great analogy.
- 33:02Speaker 15: And I'd say the same, like, the vendors who are
- 33:05Speaker 15: building this, they have responsibility to make sure that these
- 33:08Speaker 15: tools they're.
- 33:08Speaker 3: Building are right.
- 33:09Speaker 15: But you as the pharmacy and the pharmacist, you know,
- 33:12Speaker 15: you have that responsibility to make sure the vendors are
- 33:14Speaker 15: coming in and doing the right thing.
- 33:15Speaker 3: And it's a true partnership. I mean, the vendors who
- 33:17Speaker 3: are doing it right.
- 33:19Speaker 15: Integrity is maybe a hard word to use, but the
- 33:21Speaker 15: ones who are really here for the right reasons or
- 33:24Speaker 15: genuinely trying to help, they'll assume that risk. They'll partner
- 33:27Speaker 15: up with you. It's not going to be like, hey,
- 33:29Speaker 15: you shouldn't have turned it on. They're really there to
- 33:32Speaker 15: also take ownership and take some responsibility. I think it's
- 33:37Speaker 15: a great analogy you said about the tech and the pharmacist.
- 33:39Speaker 15: The buck always stops at the pharmacist. It really does,
- 33:42Speaker 15: which is good. That's who we want the buck to
- 33:43Speaker 15: stop with.
- 33:44Speaker 12: All right.
- 33:45Speaker 5: So when's the Terminator going to come destroy us do
- 33:48Speaker 5: you think how many years is it going to take
- 33:50Speaker 5: for ai to say you know forget you humans um
- 33:53Speaker 5: we want it all.
- 33:54Speaker 15: Yeah i don't i think we'll still be here november
- 33:57Speaker 15: december i think we're safe at least for now we'll
- 34:00Speaker 15: be here i was going to say my friend i
- 34:01Speaker 15: got to point out the uh the top host award
- 34:03Speaker 15: that i'm hearing about oh yeah anyone more deserving of
- 34:07Speaker 15: it than todd in the podcast the pharmacy podcast network.
- 34:10Speaker 5: But sean's talking about something that's coming so i heart
- 34:13Speaker 5: media I was nominated, and I'm not sure who nominated me,
- 34:17Speaker 5: but they reached out to me and they said, you're
- 34:19Speaker 5: being looked at as a top host. And I immediately
- 34:24Speaker 5: want to push that back to the work I do
- 34:27Speaker 5: in rising the voice of pharmacists and people in pharmacy
- 34:31Speaker 5: because I still feel like pharmacy is the redheaded stepchild
- 34:37Speaker 5: of healthcare and gets pushed to the back. They almost
- 34:40Speaker 5: make it transactional. And if people like Mark Cuban, for example,
- 34:45Speaker 5: who's made comments about specialty pharmacy several times, he needs
- 34:49Speaker 5: to come to the NASP or he needs to come
- 34:51Speaker 5: to Assembia and realize, holy crap, specialty pharmacy really is
- 34:56Speaker 5: as intensive as they say. And just because you have
- 34:58Speaker 5: bad players out there that have taken advantage of formulary
- 35:02Speaker 5: or pricing or rebate and don't put all the bad
- 35:06Speaker 5: eggs in the same basket under the guise of what
- 35:09Speaker 5: is specialty pharmacy. So if I win that award and
- 35:12Speaker 5: it should be awesome, it's all being pushed back to
- 35:15Speaker 5: the exposure of what's happening in our industry.
- 35:18Speaker 3: That's awesome. Yeah, no, no one deserves it more than you.
- 35:20Speaker 3: So I'm wishing you luck.
- 35:21Speaker 15: I think, To answer your question, I think we'll be
- 35:24Speaker 15: here when the voting comes out.
- 35:26Speaker 3: AI won't take us out by then.
- 35:27Speaker 5: So we will see you cry on the top host. AI,
- 35:31Speaker 5: I heard, is trying to take over podcasting. And they're like, hey,
- 35:34Speaker 5: plug your voice into this system and it'll give it
- 35:37Speaker 5: a script and it'll build a podcast. And I'm like,
- 35:39Speaker 5: that's not what podcasting is. Podcasting is about the human
- 35:43Speaker 5: to human speaking about something very intimate and it differentiates them.
- 35:49Speaker 5: any other form of media. It differentiates from video. It
- 35:52Speaker 5: differentiates from blogging. And it's very special. So I don't, like,
- 35:57Speaker 5: I'm always going to fight if someone's like, hey, it's
- 35:59Speaker 5: an AI podcast. I don't listen to AI podcasts. I
- 36:02Speaker 5: think I've listened to one or two just to say
- 36:04Speaker 5: I've listened, but I refuse to listen to a machine
- 36:08Speaker 5: talking to another machine.
- 36:10Speaker 3: Yeah, no, totally.
- 36:10Speaker 15: And I mean, that's like, that's what makes podcasting so appealing.
- 36:14Speaker 15: I mean, it's just, it's so genuine. That's like, the
- 36:16Speaker 15: best host, it's always like a genuine conversation.
- 36:19Speaker 3: People like that.
- 36:20Speaker 9: It's real.
- 36:20Speaker 3: It's unscripted. It's unfiltered.
- 36:22Speaker 1: Right.
- 36:22Speaker 3: That's how it should be.
- 36:23Speaker 15: I mean, nobody wants to hear a polished AI podcast.
- 36:26Speaker 3: That's true.
- 36:27Speaker 5: At least I don't.
- 36:27Speaker 3: Yeah, I don't either. All right.
- 36:29Speaker 5: Sean Jensen, so good to have you back on the
- 36:32Speaker 5: NASP podcast. And we'll have you back soon on Twerks.
- 36:35Speaker 3: Sounds great. So happy to be here. And thanks for
- 36:37Speaker 3: everything you do, Todd.
- 36:38Speaker 16: Specialty pharmacy teams are being asked to do more than
- 36:41Speaker 16: ever before. Between patient outreach, refill coordination, prior authorizations, and
- 36:46Speaker 16: the endless volume of phone calls, valuable clinical and operational
- 36:50Speaker 16: time is often consumed by administrative work. At Hendren AI,
- 36:54Speaker 16: we believe the people caring for patients should spend less
- 36:57Speaker 16: time managing workflows and more time delivering meaningful outcomes. That's
- 37:02Speaker 16: why we build AI-powered solutions designed specifically for specialty and
- 37:06Speaker 16: infusion pharmacy organizations. Our platform helps automate repetitive phone-based and
- 37:11Speaker 16: administrative processes, streamline operations, and improve the patient experience while
- 37:16Speaker 16: fitting into existing workflows. Hendren AI is focused on a
- 37:20Speaker 16: simple mission, turning human labor into software so healthcare organizations
- 37:25Speaker 16: can scale more efficiently while keeping patients at the center
- 37:28Speaker 16: of care. To learn more, visit Hendren.ai and discover how
- 37:33Speaker 16: AI can help your team work smarter, not harder.
- 37:40Speaker 7: Hey, it's Ulrich Dvorsky, co-founder and CEO of Telomed, and
- 37:43Speaker 7: you are listening to the Pharmacy Podcast.
- 37:50Speaker 5: Julik, here at the Inspire 2026 NASP Podcast. It's great
- 37:55Speaker 5: to have you back.
- 37:57Speaker 9: It's great to be back.
- 37:58Speaker 5: I don't know if you ever watched Saturday Night Live
- 38:00Speaker 5: back in the 80s, but they started this yellow jacket
- 38:03Speaker 5: thing where if the host... was on SNL as the
- 38:09Speaker 5: host for like the fourth time, they get to don
- 38:11Speaker 5: the jacket. Do I need to get you a jacket?
- 38:13Speaker 9: Do I get a jacket or something?
- 38:14Speaker 5: We need to get you a jacket. You're on the
- 38:16Speaker 5: shows all the time. So it's good to see you.
- 38:20Speaker 5: Something that I like is that I've been tracking the
- 38:23Speaker 5: success of TaylorMed and what you've done and how it's improved,
- 38:26Speaker 5: especially specialty pharmacy care for years. through Assembia, through NASP,
- 38:31Speaker 5: some of the things we've done on our own. You're
- 38:34Speaker 5: one of the first organizations to really be talking about
- 38:37Speaker 5: how you were going to leverage artificial intelligence into workflow
- 38:41Speaker 5: and into specialty. Had to be four or five years
- 38:44Speaker 5: ago before it was now everybody's like, I got AI.
- 38:47Speaker 5: And I'm like, that's great. But I almost don't trust
- 38:50Speaker 5: AI unless it's in the hands of an organization that
- 38:53Speaker 5: was building things way before AI was even a thing,
- 38:56Speaker 5: which is interesting. But you were featured on a panel
- 39:00Speaker 5: at Inspire 2026. I want you to give our listeners
- 39:03Speaker 5: kind of a summary of that panel.
- 39:05Speaker 9: Yeah, it was actually a panel that I moderated.
- 39:08Speaker 7: We brought a few different voices. We brought Tina from KabaFusion,
- 39:12Speaker 7: we brought Dave from UC Davis, and we brought Jen
- 39:16Speaker 7: from Bon Secours Mercy Health. And it was a fun
- 39:18Speaker 7: panel because it wasn't just to promote how easy things
- 39:22Speaker 7: are in the age of AI, and it also wasn't
- 39:24Speaker 7: like to talk about the apocalypse that is coming up
- 39:28Speaker 7: for humanity, but it was trying to give very concise
- 39:33Speaker 7: feedback and how to think about adoption and implementation of
- 39:37Speaker 7: AI across organizations, and obviously within especially pharmacy and just
- 39:42Speaker 7: in general pharmacy workflows. We talked about three different topics, affordability, access,
- 39:47Speaker 7: and prioritization.
- 39:49Speaker 9: And adherence. And I would say it was interesting to see.
- 39:51Speaker 7: How each had some level of results already with AI
- 39:58Speaker 7: tools that they work, whether it's our platform or other platforms,
- 40:03Speaker 7: early results on how they measure it, which I think
- 40:05Speaker 7: is key. But also a lot of questions about how
- 40:09Speaker 7: do we consolidate a lot of different initiatives across the
- 40:12Speaker 7: organization to provide from silos, which was A big topic
- 40:16Speaker 7: in the panel because not everybody has that solution. We
- 40:19Speaker 7: also talked about how do you measure ROI when you're
- 40:22Speaker 7: thinking about AI? Because everybody now is asking you and
- 40:24Speaker 7: is asking in the boardroom to implement AI and to
- 40:27Speaker 7: make sure that we are ahead of the curve.
- 40:29Speaker 9: What does it actually mean?
- 40:30Speaker 7: And how do you approach an initiative or choose a
- 40:32Speaker 7: vendor where you know what you're solving for?
- 40:35Speaker 9: What are the KPIs that you're going to track?
- 40:37Speaker 7: Establish a baseline and justify the overall investment from IT
- 40:41Speaker 7: to your team to the change management. So it was,
- 40:43Speaker 7: I think, a very good discussion, and I think one
- 40:47Speaker 7: that was transparent and vulnerable, but we ended on what
- 40:52Speaker 7: is the future going to look like. I think for
- 40:54Speaker 7: us at TaylorMade, what we've seen is that the more
- 40:57Speaker 7: you implement agents and the more you start seeing manual
- 41:01Speaker 7: tests that we've been requiring 12, 15, 25 FTEs before,
- 41:07Speaker 7: fully identified, it frees those people up to really do
- 41:10Speaker 7: patient care, and you are starting to create we call
- 41:14Speaker 7: it in TaylorMade, instead of having a co-pilot AI to
- 41:18Speaker 7: the human, the human is becoming a co-pilot to the
- 41:20Speaker 7: agent where it's only being dispatched tasks that the agent
- 41:23Speaker 7: couldn't complete and focus on patient care every other part
- 41:28Speaker 7: of their day.
- 41:29Speaker 9: So it was a great panel.
- 41:31Speaker 5: And then the collection of that interaction with the patient,
- 41:35Speaker 5: with all of the ancillary things happening in their lives.
- 41:38Speaker 5: When I think of, transportation issues to the hospital or
- 41:42Speaker 5: your appointment or maybe they're living alone and they need
- 41:47Speaker 5: someone to check up on them more often. I think
- 41:50Speaker 5: that specialty with AI is on a whole other level
- 41:55Speaker 5: in comparison to some of the other sectors of pharmacy
- 41:58Speaker 5: because specialty pharmacists are used to doing these extra things already.
- 42:03Speaker 5: So what other things other than I understand prior authorization
- 42:08Speaker 5: and predictive analytics was a buzzword 10 years ago. Now
- 42:13Speaker 5: it can come alive because you could ask the AI agent, hey,
- 42:17Speaker 5: run a report on me of all of the lab
- 42:20Speaker 5: work for this patient over the last 10 years. Give
- 42:24Speaker 5: us a prediction and blah, blah, blah, whatever it is.
- 42:27Speaker 5: But what else do you see in the realm of
- 42:29Speaker 5: rare disease management that AI is going to really be
- 42:32Speaker 5: able to help operations and systems with?
- 42:35Speaker 9: I think Exactly what you said.
- 42:37Speaker 7: Everybody is talking about before first fill, and we do
- 42:41Speaker 7: a ton of work there in prior auth, in affordability.
- 42:44Speaker 7: But what happens when the patient starts therapy? There is
- 42:47Speaker 7: a whole very long, hopefully, journey for persistence and adherence.
- 42:52Speaker 7: And there are many other barriers that patients are facing,
- 42:55Speaker 7: and nobody is there to help them. Especially pharmacists are
- 42:58Speaker 7: doing an awesome job trying to do that. They are
- 43:00Speaker 7: thinking about transportation, education, healthcare. calling patients to remind them
- 43:05Speaker 7: to come to their next infusion therapy or to refill
- 43:08Speaker 7: their next oral therapy. But it's a very antiquated, heavy
- 43:14Speaker 7: call center model. AI completely changes that. Tailwind launched two
- 43:17Speaker 7: years ago the first patient journey companion that basically allows
- 43:22Speaker 7: patients to self-serve. And we started where we were kind
- 43:24Speaker 7: of focused at the moment, which was affordability. And we
- 43:27Speaker 7: created this automated copay wallet that patients can use and enroll.
- 43:33Speaker 7: We are now expanding that to look at the full
- 43:35Speaker 7: orchestration of the journey. So as a specialty pharmacy, a
- 43:38Speaker 7: lot of my core services and enhanced services that I
- 43:40Speaker 7: do for patients, that I do with life science companies,
- 43:44Speaker 7: can now be fully built in to TaylorMed. And you
- 43:46Speaker 7: can orchestrate the entire journey and have your call center
- 43:49Speaker 7: be the escalation point. And I think AI enables that,
- 43:53Speaker 7: but also the patient engagement component. Because otherwise, if AI
- 43:57Speaker 7: is only powering back office work, how would patients get
- 44:00Speaker 7: the benefits of those tools?
- 44:02Speaker 5: So I have always known TaylorMed to be at the
- 44:05Speaker 5: center of specialty pharmacy and supporting our specialty pharmacists and operations.
- 44:10Speaker 5: Are there other sectors of pharmacy that TaylorMed is either
- 44:13Speaker 5: in that we don't know about or looking at getting into?
- 44:17Speaker 9: A lot.
- 44:19Speaker 7: So TaylorMed's network now reaches about 75 million patients a year.
- 44:23Speaker 9: Jeez, that's great.
- 44:23Speaker 8: 1,000 hospitals, 5,000 clinics, 3,100 pharmacies.
- 44:30Speaker 7: With those pharmacies, obviously, especially pharmacies, but we are taking,
- 44:34Speaker 7: I think, over the entire ambulatory infusion center space with
- 44:39Speaker 7: big accounts joining our network every month. From a health
- 44:44Speaker 7: system perspective, we partner with the second largest health systems
- 44:47Speaker 7: in the country earlier this year, just going live now
- 44:50Speaker 7: across all of their hospitals, clinics, pharmacies. And from a
- 44:55Speaker 7: strategy perspective, we want to be everywhere medication is written.
- 44:59Speaker 9: And or dispensed.
- 45:01Speaker 7: That means that any medication encounter, whether it's an inpatient, outpatient, specialty, pseudo-specialty, retail,
- 45:08Speaker 7: is something that we support. And the last thing we
- 45:10Speaker 7: did in order to continue to embody that strategy is
- 45:13Speaker 7: we are actually now.
- 45:14Speaker 9: Available on consumer websites.
- 45:16Speaker 7: There are pharmacies, retail pharmacies, that when you go to
- 45:18Speaker 7: their website and you search for a drug, if there
- 45:21Speaker 7: are copay cards available, we power that. So we want
- 45:23Speaker 7: to make sure that patients are exposed to those options
- 45:25Speaker 7: everywhere they are getting their care or searching for An
- 45:29Speaker 7: available option.
- 45:30Speaker 5: All right. Where's the next event that you'll be attending
- 45:33Speaker 5: where TaylorMet will be?
- 45:35Speaker 7: AVBCC in New York. It's the Association of Value-Based Cancer Care,
- 45:42Speaker 7: I think. Hopefully I didn't butcher it. But I think
- 45:46Speaker 7: it's a very important one because oncology as a whole
- 45:49Speaker 7: is its own industry because of the complexities of both
- 45:52Speaker 7: the disease but also the treatments and what does it
- 45:55Speaker 7: take to get there.
- 45:57Speaker 9: I will be actually on a panel.
- 45:58Speaker 7: There talking about how providers, pharmacies, life sciences companies, and
- 46:04Speaker 7: hubs are working together. I think the models are changing,
- 46:08Speaker 7: and we're trying to help them be broken a little bit.
- 46:12Speaker 7: And it goes back to what technology now unlocks. So,
- 46:15Speaker 7: very excited about this one.
- 46:17Speaker 5: The website, taylormed.com?
- 46:19Speaker 12: Yeah.
- 46:19Speaker 9: Okay.
- 46:19Speaker 5: So, if you want more information, you'd like to engage
- 46:22Speaker 5: with Shrilak, he's absolutely brilliant, and their team, go to taylormed.com. Sure,
- 46:28Speaker 5: like this has been awesome. Thanks for making this a tradition.
- 46:31Speaker 9: Thanks so much.
- 46:31Speaker 7: Looking forward to the fifth time and maybe like a
- 46:34Speaker 7: little jacket.
- 46:35Speaker 9: Yellow jersey or something. Thanks, Todd. Appreciate it.
- 46:39Speaker 12: Tim Mohamedou, Senior Vice President of Pharmacy for Plentiful. And
- 46:43Speaker 12: you're listening to the Pharmacy Podcast Network.
- 46:48Speaker 5: Tim, welcome to the NASP podcast here at Inspire 2026.
- 46:52Speaker 5: It's great to have you.
- 46:53Speaker 8: On the show.
- 46:54Speaker 9: Thank you. It's a pleasure being here.
- 46:56Speaker 5: All right, so we have a couple interviews from Plenful.
- 47:00Speaker 5: I'm glad that you're here because I'd like to really
- 47:03Speaker 5: talk about some of the modeling and some of the
- 47:06Speaker 5: use of artificial intelligence to customize some of the most
- 47:10Speaker 5: complex workflow systems in all of pharmacy that are inside
- 47:14Speaker 5: specialty pharmacy. The reason is, is as a disease state
- 47:18Speaker 5: continues to be modified in management and in treatment, it
- 47:23Speaker 5: now starts to become individualized. It's being individualized by the
- 47:27Speaker 5: labs and by pharmacogenomics and by ancillary treatment, helping the
- 47:33Speaker 5: patient live better throughout that disease state. And it all
- 47:38Speaker 5: comes back to, of course, my favorite provider, the pharmacist.
- 47:42Speaker 9: That's you.
- 47:43Speaker 5: So talk to us about your background a little bit
- 47:45Speaker 5: and what you do at Plentiful.
- 47:47Speaker 12: Yeah. I'm a pharmacist by training, like many of your
- 47:52Speaker 12: guests and spent the majority of my career on the
- 47:55Speaker 12: health system side, leading pharmacy services for.
- 48:00Speaker 3: Health systems across the.
- 48:01Speaker 12: Country, and then transitioned into the healthcare technology space. And
- 48:06Speaker 12: I've spent six years there with two different organizations, most
- 48:10Speaker 12: recently with Plentful, and really thinking about how we leverage
- 48:14Speaker 12: AI and technology automation to move pharmacy forward.
- 48:18Speaker 5: So that's so important. More pharmacists in technology, they used
- 48:23Speaker 5: to call it infomatics. That's still kind of a thing,
- 48:26Speaker 5: but that's really grown. And I think with the advent
- 48:29Speaker 5: of AI in pharmacy, it's going to give a lot
- 48:32Speaker 5: of nerdy pharmacists out there an opportunity to apply their
- 48:36Speaker 5: understanding of something very specific into AI. So let's talk
- 48:40Speaker 5: about You mentioned before we started recording how Plenful is
- 48:45Speaker 5: customizing workflows and some of the modeling that you've done.
- 48:48Speaker 5: I think that's super interesting, so let's dig into that.
- 48:51Speaker 12: Yeah, I think what's become really exciting with some of
- 48:54Speaker 12: our world-class technologists at Plenful is being able to use
- 48:58Speaker 12: memory to really advance and customize the models for specific
- 49:03Speaker 12: pharmacy workflow automations. And a good example is in the
- 49:09Speaker 12: prior authorization, benefit investigation, and intake process, where we really
- 49:14Speaker 12: look at two different types of memory. One would be
- 49:17Speaker 12: an institutional memory, where we have specific utilization, prescribing patterns,
- 49:26Speaker 12: cost and purchase data, margin profiles from our specific partners.
- 49:31Speaker 12: And then we also have larger ecosystem data that's available
- 49:35Speaker 12: across the industry as a formularies by specific prescription drug
- 49:42Speaker 12: plans or medical insurance. And when our partners start with
- 49:46Speaker 12: a model, I think oftentimes we provide a confidence score
- 49:51Speaker 12: on that. And they're able to see how much we
- 49:57Speaker 12: can advance the confidence scores. Maybe we're starting at 50
- 50:01Speaker 12: or 60%. And then as we start to use some
- 50:04Speaker 12: of their institutional specific memory on their specific practices, their workflows,
- 50:10Speaker 12: we can move those confidence scores of the model's ability
- 50:14Speaker 12: to move agentic workflow through that at 90, 95% confidence.
- 50:19Speaker 3: So it's been really exciting.
- 50:21Speaker 5: How does the interaction with the patient, plugging that information
- 50:26Speaker 5: that you're pulling from the patient, whether that's through texting,
- 50:30Speaker 5: whether through it's an interview, telemedicine, how is that information
- 50:34Speaker 5: being multiplying and deviating the decisions that Plenfo helps to
- 50:41Speaker 5: design to start customizing, to further customize the patient experience?
- 50:48Speaker 9: Yeah, great question.
- 50:49Speaker 12: One of the things that I think is really important
- 50:51Speaker 12: to our partners is to have some level of governance.
- 50:54Speaker 12: It's great to have a feedback mechanism. We talked about
- 50:57Speaker 12: the institutional memory that the model can take and learn from.
- 51:00Speaker 12: But we still want an individual with their clinical expertise,
- 51:04Speaker 12: their pharmacy background, to make sure that that's a decision
- 51:08Speaker 12: that they want the model to accept and apply moving forward.
- 51:11Speaker 12: So we think about this sort of twofold, where we're
- 51:14Speaker 12: using institutional memory, but we're also leveraging the expertise of
- 51:18Speaker 12: pharmacists and then those stakeholders involved in that workflow to
- 51:22Speaker 12: make sure that that information is pertinent and applicable to
- 51:25Speaker 12: the models that we're using.
- 51:26Speaker 5: All right. And the... administration of the system. I always
- 51:34Speaker 5: think of the pharmacy management system, NCPDP has the script qualification,
- 51:42Speaker 5: you have CPT codes, ICD-9, or ICD-10 now, database management.
- 51:49Speaker 5: Where does Plenful come into that ecosystem?
- 51:53Speaker 12: Yeah, we're really, I think, transferable across a variety of
- 51:57Speaker 12: those different pieces it really depends on the use case
- 52:00Speaker 12: we support pharmacy automation through a variety of different areas
- 52:04Speaker 12: everything from the 340b program plentiful can be used as
- 52:09Speaker 12: a compliance tool a way to optimize and grow your
- 52:13Speaker 12: 340b program we also do some work in financial reconciliation
- 52:17Speaker 12: with the complexity around medicare fair price refunds And then
- 52:22Speaker 12: most recently, what we've been spending some time on is
- 52:25Speaker 12: the intake benefit investigation and prior authorization process for medication access.
- 52:30Speaker 12: So all of those areas are opportunities to leverage AI, automation,
- 52:36Speaker 12: and again, opportunities to utilize the institutional specific memory to
- 52:41Speaker 12: have more of an agentic experience and supplement your team.
- 52:45Speaker 5: Where did you start your pharmacy career? implementation of Plenful?
- 52:50Speaker 5: Was it in specialty, retail chain, compounding, hospital system?
- 52:55Speaker 8: Where did it start?
- 52:58Speaker 3: Depends on the use case.
- 53:00Speaker 12: We support each of those different market segments, whether it's
- 53:04Speaker 12: an independent specialty pharmacy, whether it's a health system that's
- 53:07Speaker 12: looking at their larger market access from medical infusion, ambulatory infusion,
- 53:14Speaker 12: their hospital outpatient departments. We also work with some of
- 53:17Speaker 12: the largest national home infusion companies in the country.
- 53:21Speaker 5: Excellent. Well, that means I want you back on the
- 53:23Speaker 5: show because I'd like to dig in more into the
- 53:26Speaker 5: application of Plenful because we usually divide our coverage based
- 53:31Speaker 5: on the sector. And there's, oh, my goodness, 8 to
- 53:35Speaker 5: 12 sectors out there of pharmacies. So there's plenty of
- 53:39Speaker 5: Plenful that we could be talking about.
- 53:41Speaker 3: I love it.
- 53:42Speaker 9: Sounds great.
- 53:42Speaker 5: Thank you, Tim.
- 53:43Speaker 9: Thank you.
- 53:45Speaker 14: Hello, this is Vivian Bernice, VP of Business Development at ThermoSafe,
- 53:50Speaker 14: and you're listening to the Pharmacy Podcast.
- 53:54Speaker 5: Hey, welcome to Inspire 2026, the NASP podcast. It's so
- 53:59Speaker 5: good to see you.
- 54:00Speaker 9: Thank you.
- 54:01Speaker 7: Likewise, Todd.
- 54:02Speaker 14: Thanks for having us.
- 54:03Speaker 7: All right.
- 54:04Speaker 5: Is this your first event? Is this your first Inspire 2020?
- 54:07Speaker 5: It's everybody's first Inspire 2026. It's a brand new conference,
- 54:11Speaker 5: but The NASP. Is this the first NASP?
- 54:14Speaker 3: It is.
- 54:15Speaker 14: My first event, and I cannot rave about the energy enough.
- 54:19Speaker 14: I mean, the warmth, the accessibility of everybody, it's been
- 54:22Speaker 14: so welcoming. It's been a wonderful experience so far.
- 54:26Speaker 5: So I attend between 8 to 12, if my wife
- 54:30Speaker 5: allows me, events per year. And it's a lot of
- 54:34Speaker 5: conference going. And I want to echo what you say,
- 54:38Speaker 5: because the NASP... I think they're the first national organization
- 54:45Speaker 5: to give me a press pass in access to their booth,
- 54:50Speaker 5: where I'm embedded into the NASP booth as an extension
- 54:53Speaker 5: of their communications team. And they give me 100% trust
- 54:58Speaker 5: to their brand and to their name. And it just
- 55:02Speaker 5: gives me chills. It's just like they're such a welcoming organization.
- 55:06Speaker 5: And I think that echoes throughout the entire Inspire event.
- 55:11Speaker 5: And just a shout out to Sheila Arquette and her team.
- 55:14Speaker 5: What you said is very special because as a first-time attendee,
- 55:17Speaker 5: you're already picking that up. There's a lot of conferences
- 55:20Speaker 5: where it's like very clubbish. And it's like you have to.
- 55:25Speaker 5: It's kind of like the popular kids' table at high school,
- 55:29Speaker 5: and it's not like that here. No, not at all, actually.
- 55:32Speaker 14: Even the lunch breakfast experiences, you're being welcomed by strangers
- 55:36Speaker 14: just because you have a unified mission and inspire NSAP.
- 55:41Speaker 14: They really embody that, and I think really, truly, everybody
- 55:46Speaker 14: that's here is an extension of that, and so, therefore,
- 55:48Speaker 14: it just becomes a natural aspect of the ambiance, right?
- 55:51Speaker 12: Yeah, exactly.
- 55:52Speaker 5: Exactly. All right, so specialty pharmacy, super complex. People with
- 55:58Speaker 5: diseases they find out they have, it wrecks their life.
- 56:02Speaker 5: It brings a lot of trauma for them and their families.
- 56:05Speaker 5: An aspect of specialty that keeps it extremely special is
- 56:10Speaker 5: the aspect of delivery and the protection of the medications.
- 56:16Speaker 5: The temperature safety, the temperature sensitivity. Talk to us about
- 56:20Speaker 5: your mission and your organization and how you plug into
- 56:24Speaker 5: specialty pharmacy.
- 56:26Speaker 14: That question carries so much weight to it because it really,
- 56:29Speaker 14: at the end of the day, if you look at it,
- 56:31Speaker 14: it's so much more beyond just operations of getting something
- 56:35Speaker 14: from point A to point B.
- 56:37Speaker 5: It's about the patient.
- 56:39Speaker 14: At the end of that transaction or exchange, that patient
- 56:45Speaker 14: is receiving... maybe a life-extending, life-enriching, life-saving medication, which ultimately
- 56:52Speaker 14: is being fueled by science. And the way that that
- 56:55Speaker 14: science works is chemistry. And what happens with chemistry? Well,
- 57:00Speaker 14: you know, if anybody's done that volcano experiment, if you
- 57:03Speaker 14: put in a little bit of vinegar, you add some
- 57:07Speaker 14: baking soda into the mix, something happens, right? Well, that's visible.
- 57:13Speaker 14: You can see that. What you can't see in the
- 57:17Speaker 14: context of the complexity of medications is what's happening at
- 57:20Speaker 14: the molecular level when that medication is exposed to high
- 57:25Speaker 14: heat temperatures for an extended period of time, which in
- 57:30Speaker 14: most cases, that efficacy is put at risk. So if
- 57:34Speaker 14: you have an oncology product, that patient's really relying on
- 57:38Speaker 14: the full maximum potential of that medication to help steer
- 57:44Speaker 14: the outcomes right from a health perspective. And so the
- 57:48Speaker 14: cold chain is an integral part of that equation to
- 57:52Speaker 14: make sure that patients are not just receiving their medication,
- 57:57Speaker 14: but they're receiving it with the utmost care. potential so
- 58:01Speaker 14: that they can get on track with ultimately why they're
- 58:04Speaker 14: adhering or even starting that plan from the get-go.
- 58:07Speaker 5: So has your organization always been within specialty from the
- 58:11Speaker 5: get-go or did you come from and evolve from a
- 58:14Speaker 5: different industry?
- 58:16Speaker 14: Excellent question. The landscape has been evolving and changing. We
- 58:20Speaker 14: have always been in the life sciences and healthcare space
- 58:24Speaker 14: and predominantly within more of a commercial take, but because
- 58:28Speaker 14: of the rise of e-commerce, the Amazon effect, COVID also
- 58:33Speaker 14: catapulted a lot of organizations to reconsider.
- 58:36Speaker 8: Their distribution practices.
- 58:38Speaker 14: And even in the specialty pharmacy space, pharmacists themselves there's
- 58:43Speaker 14: been an explosion of needs that have been generated through
- 58:48Speaker 14: the ease right of patient centricity and accessibility to purchasing
- 58:54Speaker 14: products online and that's where packaging started to come up
- 58:58Speaker 14: as a key aspect in that equation because there's the
- 59:02Speaker 14: the patient unboxing experience there's the um the regulatory piece
- 59:08Speaker 14: of it of making sure that you're a with your
- 59:11Speaker 14: accreditation if that's something that a company aspires to achieve.
- 59:15Speaker 14: And so there's a lot of facets that have ultimately
- 59:19Speaker 14: driven us to play a more predominant role and bring
- 59:23Speaker 14: awareness more than anything because as I was explaining about
- 59:27Speaker 14: the science of that volcano, There's a lot of lack
- 59:31Speaker 14: of knowledge to what actually happens when a specialty pharmacy
- 59:35Speaker 14: is starting their journey and deciding what type of packaging
- 59:38Speaker 14: they want to use to ultimately get the products into
- 59:41Speaker 14: the patient's hand.
- 59:43Speaker 5: If our specialty pharmacist that's out there, the operator, the administrator,
- 59:47Speaker 5: they're listening to the podcast and they're like, I want
- 59:50Speaker 5: to talk more about this. How do we get a
- 59:52Speaker 5: hold of you?
- 59:53Speaker 14: Very easy.
- 59:54Speaker 8: ThermoSafe.com. We're on the website.
- 59:57Speaker 14: We've got a LinkedIn platform. We're also on all of
- 59:59Speaker 14: the social media channels. We're happy to connect. Even if
- 1:00:03Speaker 14: it's just to share awareness, education, that's a large premise
- 1:00:08Speaker 14: of how we look at things. We know that this
- 1:00:11Speaker 14: space can be overwhelming if you haven't operated from within it.
- 1:00:16Speaker 14: So there may be like a large learning gap, but
- 1:00:18Speaker 14: we're here to support generally from an interest of just
- 1:00:23Speaker 14: helping to advance the industry overall toward a safer distribution
- 1:00:28Speaker 14: of products that require cold chain.
- 1:00:30Speaker 12: All right.
- 1:00:30Speaker 5: You heard it here on the NASP podcast. Thermalsafe.com. Plug
- 1:00:36Speaker 5: it in. Reach out. Ask questions. I promise that this
- 1:00:40Speaker 5: isn't your last podcast with us. We have to have
- 1:00:42Speaker 5: you back. I'd be delighted. Thank you for the opportunity.
- 1:00:45Speaker 7: All right.
- 1:00:46Speaker 3: Thank you.